Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...